The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| DoD Peer Reviewed Orthopaedic, Clinical Trial Award |
12.420 |
W81XWH-22-PRORP-CTA |
| Alcohol Treatment and Recovery Research (R34 Clinical Trial Required) |
93.273 |
PAR-22-159 |
| Alcohol Health Services Research (R01 Clinical Trial Optional) |
93.273, 93.313 |
PAR-22-156 |
| Alcohol Health Services Research (R34 Clinical Trial Optional) |
93.273 |
PAR-22-157 |
| Alcohol Treatment and Recovery Research (R01 Clinical Trial Required) |
93.273 |
PAR-22-158 |
| NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) |
93.310 |
RFA-RM-22-019 |
| Limited Competition: Research Centers in Minority Institutions (RCMI) Clinical Research Network for Health Equity (UG3/UH3 - Clinical Trial Optional) |
93.307 |
RFA-MD-22-006 |
| Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) |
93.393 |
PAR-22-161 |
| Emergency Award: Rapid Acceleration of Diagnostics Tribal Data Repository (RADx TDR) (U24 Clinical Trial Not Allowed) |
93.113, 93.242, 93.310, 93.846, 93.853, 93.859, 93.866, 93.879 |
RFA-OD-22-011 |
| Increasing Immediate Engagement and Retention in HIV Treatment with Substance Users (R01- Clinical Trials Required) |
93.279 |
RFA-DA-23-002 |
| A Community Research Resource: Characterization of the Resident Ocular Microbiome. (U24 Clinical Trial Not Allowed) |
93.867 |
RFA-EY-22-001 |
| INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) |
93.173, 93.394, 93.395, 93.846, 93.853, 93.865, 93.866, 93.867 |
RFA-OD-22-007 |
| Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed) |
93.121, 93.172, 93.173, 93.233, 93.242, 93.351, 93.393, 93.396, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.865, 93.866, 93.867 |
RFA-OD-22-009 |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) |
93.394, 93.395 |
RFA-CA-22-025 |
| Laboratories to Optimize Digital Health (R01 Clinical Trial Required) |
93.242 |
PAR-22-154 |
| Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) |
93.313, 93.394, 93.395 |
RFA-CA-22-020 |
| Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional) |
93.395, 93.396 |
RFA-CA-22-016 |
| Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-22-028 |
| Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) |
93.173, 93.233, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.865, 93.866, 93.867 |
RFA-OD-22-010 |
| NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) |
93.173 |
RFA-DC-23-001 |
| National Institute of General Medical Sciences (NIGMS) Bridges to the Baccalaureate Research Training Program (T34) |
93.859 |
PAR-22-125 |
| Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional) |
93.395, 93.396 |
RFA-CA-22-016 |
| Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-22-020 |
| DoD Prostate Cancer, Health Disparity Research Award |
12.420 |
W81XWH-22-PCRP-HDRA |
| Research Program Award (R35 Clinical Trial Optional) |
93.853 |
RFA-NS-22-038 |
| Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional) |
93.242, 93.286, 93.307, 93.866, 93.867, 93.879 |
PAR-22-145 |
| Implementation Research to Reduce Noncommunicable Disease (NCD) Burden in Low- and Middle-Income Countries (LMICs) and Tribal Nations During Critical Life Stages and Key Transition Periods (R01 Clinical Trial Optional) |
93.113, 93.242, 93.279, 93.307, 93.399, 93.853, 93.865, 93.866, 93.867, 93.989 |
PAR-22-132 |
| Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed) |
93.242, 93.279, 93.855 |
RFA-AI-22-025 |
| Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional) |
93.279 |
RFA-DA-23-021 |
| Patient Derived Xenograft (PDX) Development and Trial Centers (PDTCs) Network (U54 Clinical Trial Not Allowed) |
93.394, 93.395 |
RFA-CA-22-012 |
| PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed) |
93.396 |
RFA-CA-22-013 |
| Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) |
93.393, 93.394, 93.395, 93.396, 93.399 |
RFA-CA-22-021 |
| Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) |
93.393, 93.394, 93.395, 93.396, 93.399 |
RFA-CA-22-022 |
| Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
93.393, 93.394, 93.395, 93.396, 93.399 |
RFA-CA-22-024 |
| Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
93.393, 93.394, 93.395, 93.396, 93.399 |
RFA-CA-22-023 |
| Understanding Suicide Risk and Protective Factors among Black Youth (R01 Clinical Trial Not Allowed) |
93.242, 93.307 |
RFA-MH-22-140 |
| Understanding Suicide Risk and Protective Factors among Black Youth (R21 Clinical Trial Not Allowed) |
93.242 |
RFA-MH-22-141 |
| Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 - Clinical Trials Optional) |
93.307 |
RFA-MD-22-008 |
| BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-MH-22-220 |
| Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed) |
93.853 |
PAR-22-076 |
Search Results 1441-1480 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
